• undefined
      • undefined
    • People
    • Practices
    • Insights
        • Insights
        • Technology & Innovation
        • Orrick Tech Studio
        • Energy & Infrastructure
        • Finance
        • Life Sciences & HealthTech
        • Litigation & IP
        • Strategic Advisory & Government Enforcement (SAGE)
        • All Insights
        • Featured
        • CFPB Pause: Where From Here?
        • The Download: Tech & Innovation Market Briefing
        • AI Law Center
        • Online Safety Law Center
        • Life Sciences Venture Capital Quarterly Report
        • Channels
        • Podcasts
        • Events
    • Careers
    • About
        • About
        • About Us
        • News
        • Locations
        • Innovation
        • AI Adoption @Orrick
        • Alumni
        • Our Culture
        • Veterans' Legal Career Fair
        • Pro Bono
        • Inclusion & Belonging
        • Responsible Business @Orrick
    • Orrick Tech Studio
    • People
    • Practices
    • Insights
    • Careers
    • About
    • Orrick Tech Studio
    • Technology & Innovation
    • Energy & Infrastructure
    • Finance
    Orrick.com
     

    People


    Orrick.com
     

    Practices


    Orrick.com
     

    Insights


    • Insights
    • Technology & Innovation
    • Orrick Tech Studio
    • Energy & Infrastructure
    • Finance
    • Life Sciences & HealthTech
    • Litigation & IP
    • Strategic Advisory & Government Enforcement (SAGE)
    • All Insights
    • Featured
    • CFPB Pause: Where From Here?
    • The Download: Tech & Innovation Market Briefing
    • AI Law Center
    • Online Safety Law Center
    • Life Sciences Venture Capital Quarterly Report
    • Channels
    • Podcasts
    • Events
    Orrick.com
     

    Careers


    Orrick.com
     

    About


    • About
    • About Us
    • News
    • Locations
    • Innovation
    • AI Adoption @Orrick
    • Alumni
    • Our Culture
    • Veterans' Legal Career Fair
    • Pro Bono
    • Inclusion & Belonging
    • Responsible Business @Orrick
    Orrick.com
     

    Orrick Tech Studio


    Orrick.com
     


    Orrick.com
     

    Technology & Innovation


    Orrick.com
     

    Energy & Infrastructure


    Orrick.com
     

    Finance


    Orrick.com
     


    Orrick logo
    • Technology & Innovation
    • Energy & Infrastructure
    • Finance
    • Life Sciences & HealthTech
    Submit
    • English
    1. Home
    2. Life Sciences & HealthTech
        • Facebook
        • Twitter
        • Linkedin

    News & Client Results

    • Show more

    Genentech Achieves Victory in High-Stakes Breach of Contract Dispute and Secures Fee Award

    1 minute read | June.16.2025

    Not only did Genentech defeat Novartis’s breach of contract claim, but the arbitration tribunal also awarded Genentech $17.8M in attorneys’ fees.

    Carlyle and SK Capital Complete Acquisition of bluebird bio

    2 minute read | June.12.2025

    Global investment firms Carlyle and SK Capital Partners have completed their acquisition of bluebird bio, a pioneer in gene therapies for severe ...

    Regeneron Secures $407M Jury Verdict in Major Antitrust Win that Earns American Lawyer Litigators of the Week Top Honors

    2 minute read | May.16.2025

    This verdict will ensure that patients continue to have access to Regeneron’s lifesaving, cholesterol-reducing drug Praluent. 

    Twist Bioscience Spins Out DNA Data Storage as Independent Company

    3 minute read | May.14.2025

    twist orrick

    Twist Bioscience Corporation has spun out its DNA data storage technology application as an independent company, named Atlas Data Storage.

    Orrick Expands Life Sciences & Tech Venture Capital Practice with Boston Duo

    3 minute read | May.07.2025

    Life sciences and tech company advisors Mark Solakian and Jake Gatof join Orrick as partners.
    Leaders in the Boston venture capital ecosystem, life sciences and tech company advisors Mark Solakian and Jake Gatof join the firm as partners.

    Orrick Advises Ananda Pharma on U.S. OTCQB Listing

    2 minute read | April.16.2025

    Ananda Pharma orrick logo

    Orrick advised Ananda Pharma plc on the admission to trading of its ordinary shares on the OTCQB Venture Market (OTCQB) in the U.S.

    FemTech Leader Willow Acquires Elvie

    2 minute read | April.02.2025

    willow orrick image

    Orrick advised Willow, the FemTech leader that revolutionized the breast pumping experience, on its acquisition of Elvie.

    Events

    • Show more

    Events

    Biologics & Biosimilars: Hot Topics

    The New York Intellectual Property Law Association is hosting their event, “Biologics & Biosimilars: Hot Topics” in Orrick's NY office.

    February.05.2025 | Orrick's New York Office

    Events

    Telemedicine Requirements for Licensing and Scope of Practice

    This on-demand CLE shares best practices and priority issues in overcoming regulatory hurdles for healthcare providers and facilities in telemedicine.

    December.12.2024 |

    Events

    New York Intellectual Property Law Association’s (NYIPLA) Patent Seminar

    Orrick Intellectual Property Partner, Irena Royzman, will be speaking at NYIPLA’s One-Day Patent CLE Seminar on November 7, 2024.

    November.07.2024 | Hughes Hubbard & Reed LLP

    Events

    Women in AI and Healthcare Panel

    Please join Team Orrick and the Women’s General Counsel Network (WGCN) for an insightful discussion centered around emerging trends in AI and healthcare. We'll explore how key topics impact women and uncover valuable insights through dynamic conversations. Following the program, we invite you to ...

    September.10.2024 | Orrick San Francisco

    Events

    Fortifying Healthcare IT: Strategies to Protect Your Organization from Rising Class Action Lawsuits

    Aravind Swaminathan will co-lead a discussion on the origin of the private right of action for privacy breaches, the effects, and where it’s going.

    July.30.2024 | Virtual

    Events

    New Jersey Intellectual Property Law Association (NJIPLA) Patent Litigation Seminar 2024

    On Thursday, May 16, 2024, Intellectual Property partner Irena Royzman will lead a presentation titled "Mandatory Clinical Trial Disclosures as Prior Art" at NJIPLA's 2024 Patent Litigation Seminar.

    May.16.2024 | Gibbons P.C.

    • Linkedin
    • Twitter
    • Facebook
    • Instagram
    • English
    • 中文(中国) / Simplified Chinese
    • 中文(台灣) / Traditional Chinese
    • français / French
    • Deutsch / German
    • 日本語 / Japanese
    • Legal Notices
    • Privacy Notice
    • Cookie Notice
    • Attorney Advertising
    • Secure Login

    © 2025 Orrick, Herrington & Sutcliffe LLP. All rights reserved.

    • Austin
    • Beijing
    • Boston
    • Brussels
    • Chicago
    • Düsseldorf
    • Geneva
    • Houston
    • London
    • Los Angeles
    • Milan
    • Munich
    • New York
    • Orange County
    • Paris
    • Portland
    • Rome
    • Sacramento
    • San Francisco
    • Santa Monica
    • Seattle
    • Silicon Valley
    • Singapore
    • Tokyo
    • Washington, D.C.
    • Wheeling, W.V. (GOIC)

    Please read before sending e-mail.

    Please do not include any confidential, secret or otherwise sensitive information concerning any potential or actual legal matter in this e-mail message. Unsolicited e-mails do not create an attorney-client relationship and confidential or secret information included in such e-mails cannot be protected from disclosure. Orrick does not have a duty or a legal obligation to keep confidential any information that you provide to us. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

    By clicking "OK" below, you understand and agree that Orrick will have no duty to keep confidential any information you provide.

    • OK
    • Cancel